Mesoblast Ltd
REVASCOR (MPC)
Right Heart Failure (RHF)
Date
TBD
FDA decision · Date TBD estimated
What's at stake
The FDA's approval decision on REVASCOR (MPC) for Right Heart Failure (RHF) is due Date TBD. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 6-K
verified 13h ago
“Expect to file BLA for full approval next quarter”